Skip to content

HIV Vaccine Trial Results: Efficacy and Uncertainty

  • Chad Cipiti

First Signal of Vaccine-Mediated Protection Against HIV Infection is Both Celebrated and Questioned By Richard Jefferys On September 24, 2009, the surprising announcemnet that a vaccine combination had shown efficacy in preventing HIV infection was splashed across the world media.…

Read more

Blister Packs for ARVs: Could They Improve Adherence?

  • Chad Cipiti

Are we doing all we can to boost adherence to antiretroviral treatment? Can packaging help people take their drugs more consistently? By Bob Huff My doctor recently gave me a starter pack for a new medication. The pills were packaged…

Read more

AIDS Is Not in Recession: Treatment Shortages Increasing

  • Chad Cipiti

HIV is not in recession: This was the recurring theme of the IAS conference repeated in speeches and displayed on PowerPoint presentations. By Scott W. Morgan At the Fifth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in…

Read more

Two New TAG Publications

  • Chad Cipiti

Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…

Read more

State AIDS Drug Assistance Program (ADAP) Hepatitis Coverage

  • Chad Cipiti

Hepatitis C Treatment, Psychiatric Medications (SSRIs), Growth Factors, Hepatitis Vaccines (March 2009) Hepatitis C virus (HCV) is a common and serious comorbidity among HIVpositive people in the United States; up to 30%—approximately 332,000— are living with HCV. Hepatitis C can…

Read more

A Long-Term Survivor: The Pioneering MACS Cohort

  • Chad Cipiti

By Gregg Gonsalves Adapted from remarks given on May 12, 2009, at the Carnegie Institution for Science in Washington, D.C., at a celebration for the 25th anniversary of the Multicenter AIDS Cohort Study (MACS), an ongoing prospective study of the…

Read more

The HIV Entry Ban: What’s Next?

  • Chad Cipiti

A Talk with Nancy Ordover By Bob Huff Nancy Ordover, PhD, has served on the International Task Team on HIV-Related Travel Restrictions, convened by UNAIDS and concerned with issues relating to the human rights, public health, and economic impact of…

Read more
Back To Top